Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.23 Billion USD | 4.41% |
| 2022 | 4.4 Billion USD | -8.95% |
| 2021 | 4.83 Billion USD | 8.36% |
| 2020 | 4.46 Billion USD | -29.55% |
| 2019 | 6.33 Billion USD | 14.55% |
| 2018 | 5.53 Billion USD | -1.9% |
| 2017 | 5.63 Billion USD | -5.05% |
| 2016 | 5.93 Billion USD | 4.73% |
| 2015 | 5.66 Billion USD | 48.31% |
| 2014 | 3.82 Billion USD | 13.65% |
| 2013 | 3.36 Billion USD | 67.3% |
| 2012 | 2.01 Billion USD | 53.96% |
| 2011 | 1.3 Billion USD | 84.87% |
| 2010 | 706.47 Million USD | 139.39% |
| 2009 | 295.11 Million USD | -19.3% |
| 2008 | 365.7 Million USD | -15.04% |
| 2007 | 430.45 Million USD | -28.56% |
| 2006 | 602.54 Million USD | 8.64% |
| 2005 | 554.64 Million USD | 0.69% |
| 2004 | 550.82 Million USD | 1.51% |
| 2003 | 542.61 Million USD | 68.88% |
| 2002 | 321.29 Million USD | 56.25% |
| 2001 | 205.63 Million USD | 85.68% |
| 2000 | 110.74 Million USD | 52.13% |
| 1999 | 72.8 Million USD | 81.55% |
| 1998 | 40.1 Million USD | 133.14% |
| 1997 | 17.2 Million USD | -12.69% |
| 1996 | 19.7 Million USD | 42.75% |
| 1995 | 13.8 Million USD | 36.63% |
| 1994 | 10.1 Million USD | 9.78% |
| 1993 | 9.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 940.77 Million USD | 2.48% |
| 2024 Q2 | 987.79 Million USD | 5.0% |
| 2024 Q3 | 996 Million USD | 0.83% |
| 2023 Q1 | 1.16 Billion USD | 1.22% |
| 2023 Q2 | 1.05 Billion USD | -9.54% |
| 2023 Q3 | 1.12 Billion USD | 6.46% |
| 2023 FY | 4.59 Billion USD | 4.41% |
| 2023 Q4 | 918 Million USD | -18.11% |
| 2022 Q2 | 1.1 Billion USD | 4.34% |
| 2022 Q3 | 1.08 Billion USD | -1.9% |
| 2022 FY | 4.4 Billion USD | -8.95% |
| 2022 Q4 | 1.15 Billion USD | 6.09% |
| 2022 Q1 | 1.05 Billion USD | -8.79% |
| 2021 Q4 | 1.16 Billion USD | 4.41% |
| 2021 FY | 4.83 Billion USD | 8.36% |
| 2021 Q1 | 1.07 Billion USD | -5.45% |
| 2021 Q3 | 1.11 Billion USD | -34.67% |
| 2021 Q2 | 1.7 Billion USD | 58.33% |
| 2020 Q2 | 1.17 Billion USD | -1.18% |
| 2020 Q4 | 1.13 Billion USD | 5.08% |
| 2020 FY | 4.46 Billion USD | -29.55% |
| 2020 Q1 | 1.19 Billion USD | -54.65% |
| 2020 Q3 | 1.08 Billion USD | -8.07% |
| 2019 Q4 | 2.62 Billion USD | 110.75% |
| 2019 Q3 | 1.24 Billion USD | -1.42% |
| 2019 Q2 | 1.26 Billion USD | 5.86% |
| 2019 Q1 | 1.19 Billion USD | -4.33% |
| 2019 FY | 6.33 Billion USD | 14.55% |
| 2018 FY | 5.53 Billion USD | -1.9% |
| 2018 Q1 | 1.42 Billion USD | -5.12% |
| 2018 Q2 | 1.47 Billion USD | 3.5% |
| 2018 Q3 | 1.37 Billion USD | -6.64% |
| 2018 Q4 | 1.24 Billion USD | -9.5% |
| 2017 Q2 | 1.37 Billion USD | -1.36% |
| 2017 Q3 | 1.36 Billion USD | -1.16% |
| 2017 Q4 | 1.5 Billion USD | 10.51% |
| 2017 FY | 5.63 Billion USD | -5.05% |
| 2017 Q1 | 1.39 Billion USD | -1.34% |
| 2016 Q2 | 1.68 Billion USD | 4.55% |
| 2016 FY | 5.93 Billion USD | 4.73% |
| 2016 Q4 | 1.41 Billion USD | -9.8% |
| 2016 Q3 | 1.56 Billion USD | -6.81% |
| 2016 Q1 | 1.61 Billion USD | -7.27% |
| 2015 FY | 5.66 Billion USD | 48.31% |
| 2015 Q4 | 1.73 Billion USD | 10.31% |
| 2015 Q1 | 994.8 Million USD | -2.51% |
| 2015 Q2 | 1.36 Billion USD | 37.14% |
| 2015 Q3 | 1.57 Billion USD | 15.39% |
| 2014 Q4 | 1.02 Billion USD | 6.7% |
| 2014 Q1 | 898.5 Million USD | 3.07% |
| 2014 Q2 | 947.8 Million USD | 5.49% |
| 2014 FY | 3.82 Billion USD | 13.65% |
| 2014 Q3 | 956.3 Million USD | 0.9% |
| 2013 Q4 | 871.72 Million USD | -40.48% |
| 2013 FY | 3.36 Billion USD | 67.3% |
| 2013 Q3 | 1.46 Billion USD | 149.67% |
| 2013 Q2 | 586.56 Million USD | -1.64% |
| 2013 Q1 | 596.31 Million USD | 5.66% |
| 2012 Q2 | 471.91 Million USD | 14.28% |
| 2012 Q4 | 564.38 Million USD | -1.21% |
| 2012 Q1 | 412.92 Million USD | -10.57% |
| 2012 Q3 | 571.31 Million USD | 21.06% |
| 2012 FY | 2.01 Billion USD | 53.96% |
| 2011 Q1 | 267.61 Million USD | -11.17% |
| 2011 Q3 | 297.2 Million USD | 3.15% |
| 2011 Q4 | 461.73 Million USD | 55.36% |
| 2011 FY | 1.3 Billion USD | 84.87% |
| 2011 Q2 | 288.11 Million USD | 7.66% |
| 2010 Q3 | 176.52 Million USD | 43.25% |
| 2010 Q2 | 123.22 Million USD | -14.25% |
| 2010 Q4 | 301.28 Million USD | 70.68% |
| 2010 FY | 706.47 Million USD | 139.39% |
| 2010 Q1 | 143.7 Million USD | 20.03% |
| 2009 Q2 | 121.56 Million USD | 65.36% |
| 2009 FY | 295.11 Million USD | -19.3% |
| 2009 Q1 | 73.51 Million USD | -9.99% |
| 2009 Q4 | 119.72 Million USD | 18.43% |
| 2009 Q3 | 101.09 Million USD | -16.84% |
| 2008 FY | 365.7 Million USD | -15.04% |
| 2008 Q4 | 81.67 Million USD | 5.53% |
| 2008 Q3 | 77.39 Million USD | -32.54% |
| 2008 Q2 | 114.73 Million USD | 25.22% |
| 2008 Q1 | 91.62 Million USD | -47.87% |
| 2007 Q1 | 87.13 Million USD | -29.33% |
| 2007 Q2 | 85.14 Million USD | -2.28% |
| 2007 FY | 430.45 Million USD | -28.56% |
| 2007 Q3 | 78.25 Million USD | -8.1% |
| 2007 Q4 | 175.76 Million USD | 124.61% |
| 2006 FY | 602.54 Million USD | 8.64% |
| 2006 Q4 | 123.3 Million USD | -56.14% |
| 2006 Q3 | 281.14 Million USD | 169.3% |
| 2006 Q2 | 104.39 Million USD | 11.41% |
| 2006 Q1 | 93.7 Million USD | -61.73% |
| 2005 Q3 | 77.75 Million USD | -36.7% |
| 2005 Q4 | 244.86 Million USD | 214.91% |
| 2005 FY | 554.64 Million USD | 0.69% |
| 2005 Q2 | 122.84 Million USD | 9.56% |
| 2005 Q1 | 112.12 Million USD | -58.05% |
| 2004 Q4 | 267.28 Million USD | 163.5% |
| 2004 Q1 | 94.55 Million USD | -57.36% |
| 2004 Q3 | 101.43 Million USD | 15.85% |
| 2004 Q2 | 87.55 Million USD | -7.4% |
| 2004 FY | 550.82 Million USD | 1.51% |
| 2003 Q3 | 125.58 Million USD | 8.87% |
| 2003 FY | 542.61 Million USD | 68.88% |
| 2003 Q1 | 79.92 Million USD | -30.26% |
| 2003 Q4 | 221.74 Million USD | 76.57% |
| 2003 Q2 | 115.34 Million USD | 44.31% |
| 2002 Q3 | 76.91 Million USD | 14.02% |
| 2002 Q1 | 62.31 Million USD | 6.46% |
| 2002 FY | 321.29 Million USD | 56.25% |
| 2002 Q4 | 114.61 Million USD | 49.02% |
| 2002 Q2 | 67.45 Million USD | 8.25% |
| 2001 Q2 | 48.83 Million USD | 1.15% |
| 2001 FY | 205.63 Million USD | 85.68% |
| 2001 Q1 | 48.28 Million USD | 220.87% |
| 2001 Q4 | 58.53 Million USD | 18.14% |
| 2001 Q3 | 49.54 Million USD | 1.45% |
| 2000 Q4 | 15.04 Million USD | -60.99% |
| 2000 Q3 | 38.57 Million USD | 28.67% |
| 2000 Q1 | 27.14 Million USD | -3.05% |
| 2000 FY | 110.74 Million USD | 52.13% |
| 2000 Q2 | 29.97 Million USD | 10.44% |
| 1999 Q2 | 14.5 Million USD | 11.54% |
| 1999 Q1 | 13 Million USD | 9.24% |
| 1999 Q3 | 17.2 Million USD | 18.62% |
| 1999 Q4 | 28 Million USD | 62.79% |
| 1999 FY | 72.8 Million USD | 81.55% |
| 1998 Q2 | 9.3 Million USD | -2.11% |
| 1998 Q4 | 11.9 Million USD | 27.96% |
| 1998 FY | 40.1 Million USD | 133.14% |
| 1998 Q1 | 9.5 Million USD | 243.94% |
| 1998 Q3 | 9.3 Million USD | 0.0% |
| 1997 Q3 | 9.1 Million USD | 28.17% |
| 1997 FY | 17.2 Million USD | -12.69% |
| 1997 Q2 | 7.1 Million USD | 10.94% |
| 1997 Q1 | 6.4 Million USD | 88.24% |
| 1997 Q4 | -6.6 Million USD | -172.53% |
| 1996 Q4 | 3.4 Million USD | -30.61% |
| 1996 Q1 | 6 Million USD | 133.33% |
| 1996 FY | 19.7 Million USD | 42.75% |
| 1996 Q2 | 5.8 Million USD | -3.33% |
| 1996 Q3 | 4.9 Million USD | -15.52% |
| 1995 Q2 | - USD | -100.0% |
| 1995 Q1 | 2.9 Million USD | 120.14% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | -18 Million USD | 0.0% |
| 1995 FY | 13.8 Million USD | 36.63% |
| 1994 Q4 | -14.4 Million USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | 10.1 Million USD | 9.78% |
| 1993 FY | 9.2 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 616.19 Million USD | -749.574% |
| Catalent, Inc. | 1.7 Billion USD | -207.579% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -401.437% |
| Elanco Animal Health Incorporated | 1.61 Billion USD | -224.752% |
| Perrigo Company plc | 1.52 Billion USD | -242.493% |
| Teva Pharmaceutical Industries Limited | 4.45 Billion USD | -17.614% |
| Zoetis Inc. | 2.76 Billion USD | -89.331% |